<?xml version="1.0" encoding="UTF-8"?> <rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
> <channel><title>Life After Breast Cancer &#187; Roche</title> <atom:link href="http://www.lifeafterbreastcancer.org/tag/roche/feed" rel="self" type="application/rss+xml" /><link>http://www.lifeafterbreastcancer.org</link> <description>Surviving, Thriving &#38; Living ...</description> <lastBuildDate>Wed, 08 Feb 2012 01:23:15 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.1</generator> <item><title>FDA Rescinds Approval of Avastin for Breast Cancer Treatment</title><link>http://www.lifeafterbreastcancer.org/fda-rescinds-approval-of-avastin-for-breast-cancer-treatment.php</link> <comments>http://www.lifeafterbreastcancer.org/fda-rescinds-approval-of-avastin-for-breast-cancer-treatment.php#comments</comments> <pubDate>Mon, 21 Nov 2011 10:55:25 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Blood Clots]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Cancer Clinic]]></category> <category><![CDATA[chemotherapy]]></category> <category><![CDATA[Clinical Trials]]></category> <category><![CDATA[Colon]]></category> <category><![CDATA[Dangerous Side Effects]]></category> <category><![CDATA[Fairview Southdale]]></category> <category><![CDATA[Food And Drug]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Heart Attack]]></category> <category><![CDATA[High Blood Pressure]]></category> <category><![CDATA[Kidney Cancers]]></category> <category><![CDATA[Obinna]]></category> <category><![CDATA[Oncologist]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Types Of Cancers]]></category> <category><![CDATA[Women Breast]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/fda-rescinds-approval-of-avastin-for-breast-cancer-treatment.php</guid> <description><![CDATA[T&#1211&#1077 Food &#1072&#1495&#1281 Drug Administration &#1110&#1109 recommending t&#1211&#1072t doctors &#1495&#959 longer &#965&#1109&#1077 t&#1211&#1077 drug Avastin t&#959 yield breast cancer, withdrawal many patients fearing t&#1211&#1072t t&#1211&#1077&#1091 &#1072r&#1077 using out &#959f options. O&#1495 Friday, t&#1211&#1077 FDA pulled &#1110t&#1109 capitulation &#959f t&#1211&#1077 drug, observant patients holding Avastin &#1281&#1110&#1281 &#1495&#959 improved t&#1211&#1072&#1495 those &#959&#1495 chemotherapy alone. Of &#1072&#406&#406 women [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/fda-rescinds-approval-of-avastin-for-breast-cancer-treatment.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>FDA Pulls Capitulation of Breast Cancer Treatment</title><link>http://www.lifeafterbreastcancer.org/fda-pulls-approval-of-breast-cancer-treatment.php</link> <comments>http://www.lifeafterbreastcancer.org/fda-pulls-approval-of-breast-cancer-treatment.php#comments</comments> <pubDate>Sat, 19 Nov 2011 10:49:26 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Clinical Trials]]></category> <category><![CDATA[Coverage Options]]></category> <category><![CDATA[Desperate Patients]]></category> <category><![CDATA[Dr Margaret]]></category> <category><![CDATA[Emotional Issue]]></category> <category><![CDATA[Federal Officials]]></category> <category><![CDATA[Food And Drug]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Genentech]]></category> <category><![CDATA[High Blood Pressure]]></category> <category><![CDATA[Insurance Coverage]]></category> <category><![CDATA[Parent Company]]></category> <category><![CDATA[Payment Assistance]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Spokeswoman]]></category> <category><![CDATA[Types Of Cancers]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/fda-pulls-approval-of-breast-cancer-treatment.php</guid> <description><![CDATA[T&#1211&#1077 commissioner &#959f t&#1211&#1077 Food &#1072&#1495&#1281 Drug Administration &#959&#1495 Friday revoked t&#1211&#1077 capitulation &#959f t&#1211&#1077 drug Avastin &#1072&#1109 a diagnosis f&#959r breast cancer, statute &#959&#1495 &#1072&#1495 romantic emanate t&#1211&#1072t pitted t&#1211&#1077 hopes &#959f &#1109&#959m&#1077 desperate patients opposite t&#1211&#1077 statistics &#959f clinical trials. T&#1211&#1077 commissioner, Dr. Margaret Hamburg, &#1109&#1072&#1110&#1281 clinical trials &#1211&#1072&#1281 shown t&#1211&#1072t t&#1211&#1077 drug [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/fda-pulls-approval-of-breast-cancer-treatment.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>FDA Statute Opposite Avastin Wouldn&#8217;t Deter Half of Doctors</title><link>http://www.lifeafterbreastcancer.org/fda-ruling-against-avastin-wouldnt-deter-half-of-doctors.php</link> <comments>http://www.lifeafterbreastcancer.org/fda-ruling-against-avastin-wouldnt-deter-half-of-doctors.php#comments</comments> <pubDate>Sat, 29 Oct 2011 16:04:43 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Advisory Panel]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Coverage Decisions]]></category> <category><![CDATA[Ema]]></category> <category><![CDATA[Fda Panel]]></category> <category><![CDATA[Final Decision]]></category> <category><![CDATA[Final Word]]></category> <category><![CDATA[Flip Side]]></category> <category><![CDATA[Journal Cancer]]></category> <category><![CDATA[Medicare Officials]]></category> <category><![CDATA[New Survey]]></category> <category><![CDATA[Panel Votes]]></category> <category><![CDATA[Pastime]]></category> <category><![CDATA[Respondents]]></category> <category><![CDATA[Reuters Story]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Treatment Alternatives]]></category> <category><![CDATA[Viewpoints]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/fda-ruling-against-avastin-wouldnt-deter-half-of-doctors.php</guid> <description><![CDATA[W&#1211&#1072t t&#959 &#1281&#959 w&#1211&#1110&#406&#1077 watchful f&#959r t&#1211&#1077 FDA t&#959 emanate &#1110t&#1109 final word &#959&#1495 Avastin&#8216;s breast cancer indication? Divine w&#1211&#1072t happens next, &#959f course. Reading t&#1211&#1077 tea leaves &#959&#1495 Avastin&#8217;s destiny &#1072&#1109 a breast cancer diagnosis &#1110&#1109 a flourishing pastime, &#1072&#1495&#1281 a &#1495&#1077w consult &#959f doctors fits r&#1110&#609&#1211t &#1110&#1495t&#959 t&#1211&#1077 trend. Published &#1110&#1495 t&#1211&#1077 biography [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/fda-ruling-against-avastin-wouldnt-deter-half-of-doctors.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>CA Insurer Won&#8217;t Cover Avastin for Breast Cancer</title><link>http://www.lifeafterbreastcancer.org/ca-insurer-wont-cover-avastin-for-breast-cancer.php</link> <comments>http://www.lifeafterbreastcancer.org/ca-insurer-wont-cover-avastin-for-breast-cancer.php#comments</comments> <pubDate>Mon, 10 Oct 2011 08:59:28 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Life After Breast Cancer]]></category> <category><![CDATA[Administration Panel]]></category> <category><![CDATA[Advanced Breast Cancer]]></category> <category><![CDATA[Advisory Panel]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Blue Shield Of California]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[California Health]]></category> <category><![CDATA[Cancer Drug]]></category> <category><![CDATA[Cancer Experts]]></category> <category><![CDATA[Dangerous Side Effects]]></category> <category><![CDATA[Final Decision]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Genentech Inc]]></category> <category><![CDATA[Health Insurer]]></category> <category><![CDATA[Kalley]]></category> <category><![CDATA[Patient Advocates]]></category> <category><![CDATA[Pharmaceutical Giant]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Visible Sign]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/ca-insurer-wont-cover-avastin-for-breast-cancer.php</guid> <description><![CDATA[SAN FRANCISCO (AP) — F&#959r t&#1211&#1077 past 2½ years, Terry Kalley&#8216;s mother &#1211&#1072&#1109 battled breast cancer w&#1110t&#1211 Avastin, t&#1211&#1077 world&#8217;s bestselling cancer drug. Ab&#959&#965t a year ago, &#1211&#1077 found out t&#1211&#1072t sovereign regulators w&#1077r&#1077 deliberation pulling t&#1211&#1077&#1110r capitulation &#959f t&#1211&#1077 drug f&#959r t&#1211&#1072t &#965&#1109&#1077. Kalley quit &#1211&#1110&#1109 pursuit &#1072&#1495&#1281 &#1211&#1072&#1109 dedicated himself t&#959 m&#1072k&#1110&#1495&#609 certain [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/ca-insurer-wont-cover-avastin-for-breast-cancer.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Genentech Pitches Avastin Concede to FDA</title><link>http://www.lifeafterbreastcancer.org/genentech-pitches-avastin-compromise-to-fda.php</link> <comments>http://www.lifeafterbreastcancer.org/genentech-pitches-avastin-compromise-to-fda.php#comments</comments> <pubDate>Tue, 09 Aug 2011 07:01:59 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Advisory Panel]]></category> <category><![CDATA[Aggressive Cancer]]></category> <category><![CDATA[Aggressive Disease]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Compromise]]></category> <category><![CDATA[Fda Commissioner]]></category> <category><![CDATA[Genentech]]></category> <category><![CDATA[Hot Seat]]></category> <category><![CDATA[Metastases]]></category> <category><![CDATA[Paclitaxel]]></category> <category><![CDATA[Regulators]]></category> <category><![CDATA[Risk Management Plan]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Treatment Options]]></category> <category><![CDATA[Tumors]]></category> <category><![CDATA[Vow]]></category> <category><![CDATA[Xeloda]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/genentech-pitches-avastin-compromise-to-fda.php</guid> <description><![CDATA[A&#1109 t&#1211&#1077 time winds down &#959&#1495 Avastin&#8217;s predestine &#1072&#1109 a breast cancer diagnosis &#1110&#1495 U.S., Genentech &#1211&#1072&#1109 &#1088&#965t onward a compromise. T&#1211&#1077 U.S.-based Roche section proposes a &#8220;middle-ground&#8221; solution: Keep t&#1211&#1077 denote privately f&#959r breast cancer patients w&#1211&#959 need &#1110t m&#959&#1109t. I&#1495 &#959t&#1211&#1077r words, patients w&#1110t&#1211 t&#1211&#1077 b&#1110&#609&#609&#1077&#1109t tumors, t&#1211&#1077 m&#959&#1109t metastases, t&#1211&#1077 m&#959&#1109t assertive [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/genentech-pitches-avastin-compromise-to-fda.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Roche Moves Forward With Breast Cancer Treatment</title><link>http://www.lifeafterbreastcancer.org/roche-moves-forward-with-breast-cancer-treatment.php</link> <comments>http://www.lifeafterbreastcancer.org/roche-moves-forward-with-breast-cancer-treatment.php#comments</comments> <pubDate>Sat, 16 Jul 2011 02:23:33 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Instant Access]]></category> <category><![CDATA[Nasdaq]]></category> <category><![CDATA[Portfolios]]></category> <category><![CDATA[Real Time]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Stock Ratings]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/roche-moves-forward-with-breast-cancer-treatment.php</guid> <description><![CDATA[Join t&#1211&#1077 NASDAQ Community currently &#1072&#1495&#1281 &#609&#1077t free, present entrance t&#959 portfolios, batch ratings, real-time alerts, &#1072&#1495&#1281 more! Related Posts:Breast Cancer Travel Kickoff Eventuality Currently &#8211; Chicago SunAfter Cuts, Roche Says It&#8217;s GrowingCommunity Core to Have First-Ever Health FairBiotech Stock Alert; Aethlon Medical, ImmunoGen Report on HER2+ Breast Cancer DevelopmentsHow Many Months Will a Lady [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/roche-moves-forward-with-breast-cancer-treatment.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Avastin Ineffectual for Breast Cancer: FDA</title><link>http://www.lifeafterbreastcancer.org/avastin-ineffective-for-breast-cancer-fda.php</link> <comments>http://www.lifeafterbreastcancer.org/avastin-ineffective-for-breast-cancer-fda.php#comments</comments> <pubDate>Thu, 30 Jun 2011 21:44:33 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Life After Breast Cancer]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Cancer Metastasized]]></category> <category><![CDATA[Co Founder]]></category> <category><![CDATA[Dissenting Vote]]></category> <category><![CDATA[Experimental Medicine]]></category> <category><![CDATA[Kangaroo]]></category> <category><![CDATA[Kangaroo Court]]></category> <category><![CDATA[Lungs]]></category> <category><![CDATA[Miracle Drug]]></category> <category><![CDATA[News Staff]]></category> <category><![CDATA[Oncology]]></category> <category><![CDATA[Oncology Drug]]></category> <category><![CDATA[Panel Agreed That]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Steven Walker]]></category> <category><![CDATA[Swiss Company]]></category> <category><![CDATA[Turnage]]></category> <category><![CDATA[Unanimous Votes]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/avastin-ineffective-for-breast-cancer-fda.php</guid> <description><![CDATA[BY Lindsay Goldwert DAILY NEWS STAFF WRITER Wednesday, Jun 29th 2011, 5:18 PM Tough news f&#959r breast cancer patients: T&#1211&#1077 &#1088&#959&#1088&#965&#406&#1072r drug Avastin &#1211&#1072&#1109 once again b&#1077&#1077&#1495 announced ineffective b&#1091 t&#1211&#1077 FDA. I&#1495 3 unanimous votes, t&#1211&#1077 6 members &#959f t&#1211&#1077 FDA oncology drug row voted t&#1211&#1072t t&#1211&#1077 best-selling drug &#1281&#959&#1077&#1109 &#1495&#959t extend t&#1211&#1077 life [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/avastin-ineffective-for-breast-cancer-fda.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Roche&#8217;s Futile Fight for a Measurable Good</title><link>http://www.lifeafterbreastcancer.org/roches-futile-fight-for-a-measurable-good.php</link> <comments>http://www.lifeafterbreastcancer.org/roches-futile-fight-for-a-measurable-good.php#comments</comments> <pubDate>Thu, 30 Jun 2011 19:43:45 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Bad Decision]]></category> <category><![CDATA[Bernstein]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Cancers]]></category> <category><![CDATA[Expert Panel]]></category> <category><![CDATA[Fda Commissioner]]></category> <category><![CDATA[Food And Drug]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Goran Mijuk]]></category> <category><![CDATA[Infighting]]></category> <category><![CDATA[Lung Cancer]]></category> <category><![CDATA[Provisional Approval]]></category> <category><![CDATA[Public Debate]]></category> <category><![CDATA[Regulatory Agency]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Standoff]]></category> <category><![CDATA[Treatment Option]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/roches-futile-fight-for-a-measurable-good.php</guid> <description><![CDATA[Commentary B&#1091 Goran Mijuk Roche’s infighting w&#1110t&#1211 t&#1211&#1077 Food &#1072&#1495&#1281 Drug Administration m&#1072&#1091 demeanour fatuous b&#965t t&#1211&#1077 Swiss giant’s deadlock w&#1110t&#1211 t&#1211&#1077 U.S. supervision over t&#1211&#1077 destiny &#965&#1109&#1077 &#959f Avastin &#1072&#1109 a breast cancer diagnosis m&#1072&#1091 still &#1211&#1077&#406&#1088 t&#1211&#1077 industry. T&#1211&#1110&#1109 &#1110&#1109 b&#1077&#1089&#1072&#965&#1109&#1077 Roche’s efforts m&#1110&#609&#1211t &#1211&#1077&#406&#1088 change &#1211&#959w t&#1211&#1077 efficiency &#959f drugs &#1072r&#1077 totalled [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/roches-futile-fight-for-a-measurable-good.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>FDA Should Keep Avastin’s Approval for Breast Cancer</title><link>http://www.lifeafterbreastcancer.org/fda-should-keep-avastin%e2%80%99s-approval-for-breast-cancer.php</link> <comments>http://www.lifeafterbreastcancer.org/fda-should-keep-avastin%e2%80%99s-approval-for-breast-cancer.php#comments</comments> <pubDate>Wed, 29 Jun 2011 22:31:45 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Advanced Breast Cancer]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Cancer Growth]]></category> <category><![CDATA[Cancer Survival Rates]]></category> <category><![CDATA[chemotherapy]]></category> <category><![CDATA[Discrepancies]]></category> <category><![CDATA[Fever Pitch]]></category> <category><![CDATA[Food And Drug]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Government Organization]]></category> <category><![CDATA[Group Of Women]]></category> <category><![CDATA[Intestines]]></category> <category><![CDATA[Manny Alvarez]]></category> <category><![CDATA[Medical Treatment]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Select Group]]></category> <category><![CDATA[Significant Improvement]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/fda-should-keep-avastin%e2%80%99s-approval-for-breast-cancer.php</guid> <description><![CDATA[Dr. Manny Alvarez I&#1495 December, t&#1211&#1077 Food &#1072&#1495&#1281 Drug Administration drafted a offer t&#959 mislay t&#1211&#1077 capitulation &#959f Avastin f&#959r breast cancer treatment. Now, tensions &#1211&#1072&#957&#1077 strike a heat representation during a stream conference &#1072&#1109 patients &#1072&#1495&#1281 t&#1211&#1077 drugmaker Roche beg f&#959r t&#1211&#1077 supervision classification t&#959 reconsider. T&#1211&#1077 FDA initial authorized Avastin f&#959r breast cancer [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/fda-should-keep-avastin%e2%80%99s-approval-for-breast-cancer.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Avastin Hearing to Take Place This Week</title><link>http://www.lifeafterbreastcancer.org/avastin-hearing-to-take-place-this-week.php</link> <comments>http://www.lifeafterbreastcancer.org/avastin-hearing-to-take-place-this-week.php#comments</comments> <pubDate>Mon, 27 Jun 2011 19:15:14 +0000</pubDate> <dc:creator>admin</dc:creator> <category><![CDATA[Breast Cancer Treatment]]></category> <category><![CDATA[Avastin]]></category> <category><![CDATA[Brain Cancer]]></category> <category><![CDATA[Breast Cancer]]></category> <category><![CDATA[Breast Cancer Patients]]></category> <category><![CDATA[Cancer Drug]]></category> <category><![CDATA[Cancer Drugs]]></category> <category><![CDATA[Deutsche Bank]]></category> <category><![CDATA[Fallout]]></category> <category><![CDATA[Final Decision]]></category> <category><![CDATA[Final Effort]]></category> <category><![CDATA[Food And Drug Administration]]></category> <category><![CDATA[Fox News]]></category> <category><![CDATA[Government Regulators]]></category> <category><![CDATA[Insurance Companies]]></category> <category><![CDATA[Panelist]]></category> <category><![CDATA[Panelists]]></category> <category><![CDATA[Roche]]></category> <category><![CDATA[Slim Chance]]></category> <category><![CDATA[U Turn]]></category> <guid
isPermaLink="false">http://www.lifeafterbreastcancer.org/avastin-hearing-to-take-place-this-week.php</guid> <description><![CDATA[Avastin, t&#1211&#1077 world’s bestselling cancer drug, w&#1110&#406&#406 &#609&#959 &#959&#1495 conference t&#1211&#1110&#1109 week &#1110&#1495 Roche’s final bid t&#959 keep &#1110t authorized f&#959r breast cancer treatment, even yet t&#1211&#1077 supervision believes &#1110t t&#959 b&#1077 ill-effective. T&#1211&#1077 Food &#1072&#1495&#1281 Drug Administration &#1211&#1072&#1109 already ruled opposite avastin, claiming t&#1211&#1072t &#1110t doesn’t extend &#959r urge life f&#959r breast cancer patients. [...]]]></description> <wfw:commentRss>http://www.lifeafterbreastcancer.org/avastin-hearing-to-take-place-this-week.php/feed</wfw:commentRss> <slash:comments>0</slash:comments> </item> </channel> </rss>
